American pharmaceutical firms are meeting in London to work out treatments for coronavirus-stricken British PM Boris Johnson, who was sent to intensive care after his condition deteriorated over the weekend, the US president said.
“We’re very saddened to hear that [Johnson] was taken into intensive care this afternoon. Americans are all praying for his recovery,” President Trump said at a press briefing on Monday, adding that several “genius” drug companies had “arrived in London already” to discuss therapeutics for the prime minister.
We have contacted all of Boris’s doctors.
Trump noted that the companies were working on “rather complex” treatments which have had “incredible” results, though did not get into specifics about which drugs were under consideration.
“It’s a very complex treatment of things that they’ve just recently developed,” Trump said, adding “when you’re in intensive care, that’s a big deal” and that “hopefully they won’t be needed.”
Johnson was admitted to the hospital over the weekend some 10 days after testing positive for Covid-19, and was moved into an ICU on Monday after his condition worsened, requiring oxygen for breathing difficulties. He remains conscious, a spokesperson said, but because the illness will prevent the PM from fulfilling some of his duties, he has asked Foreign Secretary Dominic Raab to stand in for him when needed.
Like this story? Share it with a friend!